Effectiveness of Enterovirus 71 inactivated vaccines against hand, foot, and mouth disease: A test-negative case-control study
ABSTRACTThe Enterovirus A71 (EV-A71) vaccine was introduced in China in December 2015 as a preventive measure against hand, foot, and mouth disease (HFMD) caused by EV-A71. However, the effectiveness of the vaccine (VE) in real-world settings needs to be evaluated. We conducted a test-negative case-...
Main Authors: | Yutong Zhang, Jinzhao Cui, Fengfeng Liu, Yang Song, Quanyi Wang, Yanzhe Liu, Yanping Zhang, Zhongjie Li, Zhaorui Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2330163 |
Similar Items
-
Epidemiological characteristics of hand, foot and mouth disease in Shenzhen from 2008 to 2020 and effect of inactivated EV71 vaccine on disease incidence
by: Zhao-yi LIANG, et al.
Published: (2023-02-01) -
Long-Term Immunogenicity Study of an Aluminum Phosphate-Adjuvanted Inactivated Enterovirus A71 Vaccine in Children: An Extension to a Phase 2 Study
by: Nan-Chang Chiu, et al.
Published: (2024-08-01) -
Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development
by: Yu-Kang Chang, et al.
Published: (2018-11-01) -
Enterovirus A71 Vaccines
by: Mei-Ling Li, et al.
Published: (2021-02-01) -
Seroprevalence of human enterovirus A71 in Guangzhou, China, 2019–2021
by: Huimin Lian, et al.
Published: (2023-06-01)